Novus Scientific has reported the three-year pre-clinical data of the adsorbable TIGR matrix surgical mesh versus a permanent mesh in a sheep model.

The results revealed that as TIGR matrix was absorbed over time, it was replaced by connective tissue that had higher collagen content than that surrounding the permanent control mesh.

The foreign-body response to TIGR matrix also declined, but it remained persistent in the control group.

Co-inventor of TIGR Matrix Henrik Hjort said a range of clinical studies are underway to examine the results of repair using the device in a variety of soft tissue reinforcement applications.

The study was conducted at Biomatech, an independent contract research company that is part of the NAMSA group.

The TIGR matrix surgical mesh is available in US and Europe.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.